237
Participants
Start Date
June 30, 2015
Primary Completion Date
February 2, 2017
Study Completion Date
February 2, 2017
Dasotraline
Dasotraline 2 mg, 4 mg, 6 mg, once daily, flexibly dosed
Richarmond Behavioral Associates, Staten Island
Coastal Carolina Research Center, Mt. Pleasant
iResearch Atlanta, LLC, Decatur
Atlanta Center for Medical Research, Atlanta
Clinical Neuroscience Solutions, Inc, Jacksonville
Sarkis Clinical Trials, Gainesville
Florida Clinical Research Center, LLC, Maitland
Clinical Neuroscience Solutions, Inc., Orlando
Indago Research Health Center, Inc., Hialeah
Miami Research Associates, LLC, South Miami
Harmonex Neuroscience Research, Inc, Dothan
Pedia Research,LLC, Owensboro
University Hospitals Case Medical Center, Cleveland
University of Cincinnati/Department of Psychiatry and Behavioral Neuroscience, Cincinnati
Goldpoint Clinical Research, LLC., Indianapolis
Pedia Research,LLC, Newburgh
Neurobehavioral Medicine Group, Clinical Trials Division, Bloomfield Hills
Clinical Trials group at the Rochester Center for Behavioral Medicine, Rochester Hills
Capstone Clinical Research, Libertyville
St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles
Psychiatric Associates, Overland Park
IPS Research Company, Oklahoma City
Cutting Edge Research Group, Oklahoma City
Bayou City Research, Ltd., Houston
Houston Clinical Trials, LLC, Houston
Family Psychiatry of the Woodlands, The Woodlands
Clinical Trials of Texas, Inc., San Antonio
Road Runner Research, Ltd., San Antonio
BioBehavioral Research of Austin P.C., Austin
MCB Clinical Research Centers, LLC, Colorado Springs
Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas
ProScience Research Group, Culver City
Elite Clinical Trials, Inc., Wildomar
Cyn3rgy Research, Gresham
Baber Research Group, Inc., Naperville
Pharmaceutical Research Associates, Inc., Marlton
Sumitomo Pharma America, Inc.
INDUSTRY